Verona Pharma Announces May 2022 Investor Conference

LONDON and RALEIGH, NC, May 04, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), announces that the company will be participating in the following conferences in May 2022:

Virtual Symposium on Immunology and Inflammation from LifeSci Partners

When: Tuesday, May 10
Time: 9:00 a.m. ET / 2:00 p.m. BST
Location: Virtual

HC Wainwright Global Hybrid Investing Conference

When: Tuesday, May 24
Time: 3:30 p.m. ET / 8:30 p.m. BST
Location: Miami, Florida

A webcast of each conference presentation will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com.

About Verona Pharma

Verona Pharma is a clinical-stage biopharmaceutical company specializing in respiratory diseases. The Company is evaluating nebulized ensifentrine in its ENHANCE Phase 3 clinical program (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) for the maintenance treatment of COPD. Main data is expected in the third quarter of 2022 and towards the end of 2022.

If successfully developed and approved, ensifentrine has the potential to be the first therapy for the treatment of respiratory disease that combines bronchodilator and anti-inflammatory activities in a single compound. Two additional ensifentrine formulations are in Phase 2 development for the treatment of COPD: the dry powder inhaler (“DPI”) and the pressurized metered-dose inhaler (“pMDI”). Ensifentrin has potential applications in cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com.

For more information, please contact:

Verona Pharma plc Such. USA: +1-833-417-0262
Such. UK: +44 (0)203 283 4200
Victoria Stewart, Director of Investor Relations and Communications [email protected]
Slang Partners
(Requests from US Investors)
Tel: +1-212-600-1902
[email protected]
Kimberly Minarovich/Michael Barron
Optimal strategic communications
(International media and requests from European investors)
Tel: +44 (0)203 950 9144
[email protected]
Mary Clark / Rebecca Noonan / Zoe Bolt

About Stephen Arrington

Check Also

SEC football 2022: 5 conference games to watch

The college football season is approaching and excitement is building for some major SEC matchups …